by Carla Barnes | Jun 22, 2023 | News + Events - Diagnostics, Related - Clinicians, Related - Corporate, Related - Diagnostics, Related - Patients
Major Milestone for Expanded Access to FENO Testing in US Pleasanton, CA, June 22, 2023 — CAIRE Diagnostics is pleased to announce that the Fenom Pro® can now be upgraded to include a 6-second test mode available for ages 6 and up. The completed clearance (K213611) by...
by Carla Barnes | Jan 4, 2023 | News + Events - Clinicians, News + Events - Corporate, News + Events - Diagnostics, News + Events - Providers, Related - Clinicians, Related - Commercial, Related - Corporate, Related - Diagnostics, Related - Patients, Related - Providers
Company Further Expands Clinical Healthcare Portfolio for Patients Facing Pulmonary Disease Ball Ground, GA (January 4, 2023) — CAIRE Inc., the leading global manufacturer of oxygen therapy and on-site generation systems, has finalized the acquisition of St. Paul,...
by Carla Barnes | Nov 29, 2022 | News + Events - Clinicians, News + Events - Commercial, News + Events - Corporate, News + Events - Diagnostics, News + Events - Providers, Related - Clinicians, Related - Commercial, Related - Corporate, Related - Diagnostics, Related - Providers
Portfolio Expands to Include Non-Invasive Cardiorespiratory Diagnostic Systems Ball Ground, GA, USA (November 29, 2022) — CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. (MGC). MGC designs,...
by Carla Barnes | Jun 3, 2020 | News + Events - Corporate, News + Events - Diagnostics, Related - Clinicians, Related - Commercial, Related - Corporate, Related - Diagnostics, Related - Patients, Related - Providers
Establishes CAIRE Diagnostics Inc. business unit to broaden product portfolio ~ Ball Ground, GA (June 3, 2020) – CAIRE Inc., a leader in respiratory solutions for the global health care community, announced the acquisition of Spirosure, Inc. Spirosure is a...
by Carla Barnes | Jan 8, 2020 | News + Events - Diagnostics
https://www.prnewswire.com/news-releases/vyaire-medical-enters-exclusive-five-year-agreement-to-distribute-spirosures-fenom-pro-asthma-monitor-in-multiple-countries-300983457.html...
by Carla Barnes | Feb 25, 2019 | News + Events - Diagnostics
PLEASANTON, Calif., Feb. 25, 2019 — Spirosure Inc. announced today that it has received FDA clearance of its patent-protected Fenom Pro Asthma Monitor for use by allergists, immunologists and pulmonologists to help patients manage asthma by measuring the fraction of...
